Fabrizia Carli - Concepedia

Author

Fabrizia Carli

Istituto di Fisiologia Clinica ORCID

Also Known As

Emma Buzzigoli, F Carli, F. Carli, FABRIZIA CARLI, Fabrizia Carli, Mattia Laffranchi

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Istituto di Fisiologia Clinica National Research Council University of Turin Bambino Gesù Children's Hospital University of Rome Tor Vergata

About

Fabrizia Carli is an author at Istituto di Fisiologia Clinica specializing in medicine, health sciences, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	588
2	Health Sciences	5	5	499
3	Public Health	3	3	72
4	Engineering	1	1	32
5	Natural Sciences	1	1	34

Fabrizia Carli

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance Melania Gaggini, Fabrizia Carli, Chiara Rosso, Hepatology	2017	444
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease Chiara Rosso, Konstantin Kazankov, Ramy Younes, Journal of Hepatology PathologyFatty Liver DiseaseInsulin SignalingObesityMetabolic Syndrome	2019	194
The relationship between the circulating concentrations of interleukin 6 (IL-6), tumor necrosis factor (TNF) and the acute phase response to elective surgery and accidental injury. Edgar Pullicino, Fabrizia Carli, S. Poole, PubMed Acute Lung InjuryTumour Necrosis FactorImmunologyBlood LossInflammation	1990	162
Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis Martina Häckl, Clemens Fürnsinn, Christina Maria Schuh, Nature Communications	2019	108
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models Miriam Longo, Marica Meroni, Erika Paolini, Cellular and Molecular Gastroenterology and Hepatology	2021	105
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes Marica Meroni, Paola Dongiovanni, Miriam Longo, EBioMedicine	2020	90
PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH Amalia Gastaldelli, Silvia Sabatini, Fabrizia Carli, Liver International	2021	90
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of <scp>NASH</scp> even in lean individuals Chiara Saponaro, Silvia Sabatini, Melania Gaggini, Liver International	2022	82
Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA.IT randomised trial Giuseppe Della Pepa, Marco Russo, Marilena Vitale, Diabetes Research and Clinical Practice Metabolic SyndromeDiabetes ManagementLow DosageHealth SciencesDiabetes Epidemiology	2021	79
Altered Metabolic Profile and Adipocyte Insulin Resistance Mark Severe Liver Fibrosis in Patients with Chronic Liver Disease Melania Gaggini, Fabrizia Carli, Chiara Rosso, International Journal of Molecular Sciences Metabolic DisorderPathologyFatty Liver DiseaseCirrhosisObesity	2019	40

Page 1